mental disorders in these chap ters): phencyclidine-induced psychotic disorder (“Schizo-
phrenia Spectrum and Other Psychotic Disord ers”); phencyclidine-induced bipolar dis-
order (“Bipolar and Related Disorders”); phencyclidine-induced depressive disorder
(“Depressive Disorders”); and phencyclidin e-induced anxiety disorder (“Anxiety Disor-
ders”). For phencyclidine-induced intoxication delirium, see the criteria and discussion of
delirium in the chapter “Neurocognitive Di sorders.” These phencyclidine-induced disor-
ders are diagnosed instead of phencyclidine in toxication only when the symptoms are suf-
ficiently severe to warrant in dependent clinical attention. 
Other Hallucinogen-Induced Disorders
The following other hallucinogen- induced disorders are describe d in other chapters of the
manual with disorder s with which they share phenome nology (see the substance/medi-
cation-induced mental disorders in these chapters): other hallucinogen–induced psychotic
disorder (“Schizophrenia Spect rum and Other Psychotic Diso rders”); other hallucinogen–
induced bipolar disorder (“Bi polar and Related Disorders”); other hallucinogen–induced